A Study of AK104 in the First-line Treatment of Locally Advanced Unresectable or Metastatic G/GEJ Adenocarcinoma

Clinical trial NCT05008783 · COMPLETED

Trial details

NCT number: NCT05008783
Sponsor: Akeso
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Gastric Adenocarcinoma Gastroesophageal Junction Adenocarcinoma

Start date: 2021-09-17
Primary completion: 2024-12-06
Enrollment: 610

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.